CSP
8 min read
37

Interim report for the period January 1 – September 30, 2024

November 28, 2024
0

Reading Time: 5 minutes Strengthened financial position and increased production paceIn the third quarter of 2024, Cinis Fertilizer delivered its first shipload of potassium sulfate to customer Van Iperen International, who in turn resold it to growers in approximately 25 countries worldwide. After the end of

Continue Reading
CSP
7 min read
7

Jetpak Top Holding AB (publ):Interim report 1 January – 30 September 2024

November 28, 2024
0

Reading Time: 5 minutes Third quarter: 1 July – 30 September June 2024  Net revenue increased by 11,7 % to 308 858 (276 583) TSEK Organic growth amounted to 1,7 % (-13,5 %) Gross margin amounted to 28,8 % (29,4 %) Adjusted EBITA amounted to

Continue Reading
Keturah Announces Campaign for Its Developments, Introduces 5-Year Post-Handover Plan
BWI
2 min read
25

Keturah Announces Campaign for Its Developments, Introduces 5-Year Post-Handover Plan

November 28, 2024
0

Reading Time: 2 minutes Dubai, United Arab Emirates:   Keturah, the revolutionary global luxury wellbeing real estate and hospitality concept has announced the launch of a sales campaign for The Ritz-Carlton Residences, Dubai, Creekside—part of the Keturah Resort—and Keturah Reserve which runs until 30 December.  

Continue Reading
CSP
2 min read
12

Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (26.11.2024)

November 28, 2024
0

Reading Time: 2 minutes Kesko Corporation has on 27 November 2024 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 26 November 2024, BlackRock, Inc.’s holding in Kesko Corporation exceeded the

Continue Reading
CSP
6 min read
14

Leqembi[®] launched in South Korea

November 27, 2024
0

Reading Time: 4 minutes Stockholm, Sweden, November 28, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult

Continue Reading
CSP
1 min read
15

#24-407 Listing of Derivatives at NGM

November 27, 2024
0

Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market

Continue Reading
CSP
3 min read
19

Live Esports Betting: Is it different from Traditional Esports?

November 27, 2024
0

Reading Time: 2 minutes Stockholm, Sweden, November 2024 – eSportsRanker is a leading platform for esports enthusiasts, offering insights, reviews, and expert guidance on the latest trends in esports betting. Today, eSportsRanker is exploring a new way of betting: Live Esports Betting, a dynamic way to

Continue Reading
CSP
10 min read
41

Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million

November 27, 2024
0

Reading Time: 7 minutes Bioretec Ltd Inside information 27 November 2024 at 10.15 p.m. EET THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN

Continue Reading
CSP
1 min read
41

Nordea Bank Abp: Repurchase of own shares on 27.11.2024

November 27, 2024
0

Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares27.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 27.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average

Continue Reading
CSP
10 min read
11

Spermosens publishes outcome in rights issue

November 27, 2024
0

Reading Time: 7 minutes NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION

Continue Reading